ORIGINAL RESEARCH
Published on 29 May 2026
Icariin attenuates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome through SIRT3-mediated TFAM deacetylation
doi 10.3389/fphar.2026.1829772
- 616 views
- Frontiers in Pharmacology
- Cardiovascular and Smooth Muscle Pharmacology
- Research Topics
- Cardiometabolic Crosstalk: Mechanisms, Modulators, and Therapeutics in Diabetes-Induced Cardiovascular Disease
Cardiometabolic Crosstalk: Mechanisms, Modulators, and Therapeutics in Diabetes-Induced Cardiovascular Disease
1,147
Total downloads
12k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 09 Apr 2026
4-Methylcatechol attenuates diabetic myocardial disorder via the ESR1–PI3K–AKT pathway
doi 10.3389/fphar.2026.1801465
- 842 views
REVIEW
Published on 28 Nov 2025
Targeting L-arginine/NO/cGMP/KATP pathway by phytochemicals: therapeutic applications and clinical perspectives
doi 10.3389/fphar.2025.1708659
- 2,825 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Oct 2025
Comparative cardiovascular risks of canagliflozin and selective SGLT2 inhibitors in type 2 diabetes
doi 10.3389/fphar.2025.1686851
- 2,295 views
REVIEW
Published on 13 Oct 2025
Diabetic cardiomyopathy and COVID-19: intersecting pathways and amplified cardiovascular risk
doi 10.3389/fphar.2025.1683159
- 3,732 views
- 6 citations
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.